As the only FDA-approved equine PSGAG (polysulfated glycosaminoglycan) for degenerative joint disease (DJD) in horses,
Adequan® i.m. actually treats degenerative joint disease (DJD), not just its clinical signs.1,2 For over 30 years,
Adequan® i.m. has been administered by veterinarians to help horses of every discipline and level enjoy greater mobility over their lifetimes.1,3,4